Stock SGRL6 SHREE GANESH REMEDIES LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

All News Shree Ganesh Remedies Limited

Equities

SGRL6

INE414Y01015

Market Closed - Bombay S.E.
Other stock markets
 06:00:53 2024-06-07 EDT 		5-day change 1st Jan Change
847.8 INR +2.58% Intraday chart for Shree Ganesh Remedies Limited +38.45% +24.18%
06-01 Shree Ganesh Remedies Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024 CI
04-17 Shree Ganesh Remedies Begins Trial Run of Plant in Gujarat, India MT

All News

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Shree Ganesh Remedies Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024
CI
Shree Ganesh Remedies Begins Trial Run of Plant in Gujarat, India
MT
Shree Ganesh Remedies Limited Announces Company Secretary and Compliance Officer Changes
CI
Shree Ganesh Remedies Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023
CI
Shree Ganesh Remedies Limited Announces the Reconstitution of Committees and Resignation of Directors
CI
Shree Ganesh Remedies Limited Announces Director Appointments
CI
Shree Ganesh Remedies Limited Proposes Final Dividend for Financial Year 2022-23, Payable on 25 September, 2023
CI
Shree Ganesh Remedies Forms New Wholly-Owned Subsidiary in US
MT
Shree Ganesh Remedies Limited Announces Intimation for Incorporation of Wholly Owned Subsidiary Company Named Sgrl Usa Inc in United States
CI
Shree Ganesh Remedies Limited Reports Earnings Results for the First Quarter Ended June 30, 2023
CI
Shree Ganesh Remedies Gets License to Manufatcure Drugs, Other Products in Gujarat, India
MT
Shree Ganesh Remedies Limited Receives Receipt of FDA License
CI
Shree Ganesh Remedies Limited Recommends Final Dividend for the Year Ended March 31, 2023
CI
Shree Ganesh Remedies Limited Reports Earnings Results for the Full Year Ended March 31, 2023
CI
Shree Ganesh Remedies Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2023
CI
Shree Ganesh Remedies CFO Resigns
MT
Shree Ganesh Remedies Books Higher Net Profit in Fiscal Q3
MT
Shree Ganesh Remedies Appoints CFO
MT
Shree Ganesh Remedies Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022
CI
Shree Ganesh Remedies Limited Announces Appointment of Parth Kothia as Chief Financial Officer
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. SGRL6 Stock
  4. News Shree Ganesh Remedies Limited